Results 221 to 230 of about 1,851,762 (241)
Some of the next articles are maybe not open access.
Nihon rinsho. Japanese journal of clinical medicine, 2016
Interleukin-6 (IL-6) plays an important role in the pathogenesis of rheumatoid arthritis (RA). Tocilizumab, anti-human IL-6 receptor monoclonal antibody developed in Japan, prevents IL-6 from binding to IL-6 receptor blocking IL-6 signal. The clinical and radiographic efficacy of tocilizumab has proved in many clinical studies.
Yuko, Kaneko, Tsutomu, Takeuchi
openaire +1 more source
Interleukin-6 (IL-6) plays an important role in the pathogenesis of rheumatoid arthritis (RA). Tocilizumab, anti-human IL-6 receptor monoclonal antibody developed in Japan, prevents IL-6 from binding to IL-6 receptor blocking IL-6 signal. The clinical and radiographic efficacy of tocilizumab has proved in many clinical studies.
Yuko, Kaneko, Tsutomu, Takeuchi
openaire +1 more source
Seikagaku. The Journal of Japanese Biochemical Society, 1990
M, Murakami, T, Hirano
openaire +1 more source
M, Murakami, T, Hirano
openaire +1 more source
Targeted Disruption of the IL‐6 Related Genes: gp130 and NF‐IL‐6
Immunological Reviews, 1995S, Akira +4 more
openaire +2 more sources
Effects of exercise on IL-6: muscle-derived IL-6
2009Delphan, Mahmoud, Rashidlamir, Amir
openaire +1 more source
The Role of Interleukin (IL)-6/IL-6 Receptor Axis in Cancer
2023Manzoor Ahmad Mir +2 more
openaire +1 more source